Find Reverse Transcriptase Inhibitor, Nucleoside Reverse Transcriptase Inhibitor, Telbivudine Inhibitor on Industry Directory, Reliable Manufacturer/Supplier/Factory from China.

Inquiry Basket (0)
Home > Products > Microbiology > Reverse Transcriptase Inhibitor > Emtricitabine 143491-57-0

Emtricitabine 143491-57-0

Product Description

.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}


Molecular Weight:

247.25 Emtricitabine (FTC) is a Nucleoside Reverse Transcriptase Inhibitor that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus.

Biological Activity

Emtricitabine moderately reduces hepatocyte proliferation independent of
effects on mtDNA in HepG2 human hepatoma cells. Emtricitabine plus
tenofovir slightly reduced cell proliferation without affecting
mitochondrial parameters. Emtricitabine efficiently
converts to their active metabolites in PBMCs and CEM cells.
Emtricitabine combined with Tenofovir displays additive to synergistic
activity against HIV replication in PBMCs and results in strongly
synergistic anti-HIV activity in MT-2 cells against both wild-type and
mutant virus.


Emtricitabine demonstrates antiviral
activity against laboratory adapted strains of HIV-1 and HIV-2 in
various cell system. Emtricitabine also exhibits antiviral activity in
cell culture against feline and simian immuno-deficiency viruses (SIVs).
Emtricitabine consistently exhibits up to 10-fold greater activity than
lamivudine against all viruses tested in all T-cell lines.


Emtricitabine generally demonstrates greater potency in vitro in human
PBMCs than in MT-4 lines. Emtricitabine also exhibits
anti-HBV activity in vitro (EC50, 0.01–0.04 µM) that is comparable to
the anti-HBV activity of 3TC. Emtricitabine is
approximately fourfold more active than 3TC in assays in the transformed
T-cell line MT-4 infected with HIV-(1IIIB), whereas Zidovudine is more
active than Emtricitabine. Emtricitabine, Lamivudine and Zidovudine are
equally active against a panel of eight primary HIV-1 isolates from
antiretroviral-naive subjects in PBMCs.

Contact us if you need more details on 143491-57-0. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Emtricitabine 143491-57-0、143491-57-0 Emtricitabine. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Microbiology > Reverse Transcriptase Inhibitor